Milena Cristina Martins da Silva, Renan Stefferson Barradas Pereira, Antonia Cherlly Aparecida Araujo, Ednilson Gregorio da Silva Filho, Anderson de Lima Dias, Kassio Silva Cavalcante, Maísa Silva de Sousa
Among the human T-lymphotropic virus (HTLV) types, HTLV-1 is the most prevalent, and it has been linked to a spectrum of diseases, including HAM/TSP, ATLL, and hyperinfection syndrome or disseminated strongyloidiasis. There is currently no globally standard first-line treatment for HTLV-1 infection and its related diseases. To address this, a comprehensive review was conducted, analyzing 30 recent papers from databases PubMed, CAPES journals, and the Virtual Health Library (VHL). The studies encompassed a wide range of therapeutic approaches, including antiretrovirals, immunomodulators, antineoplastics, amino acids, antiparasitics, and even natural products and plant extracts...
November 2, 2023: Pharmaceuticals